-+ 0.00%
-+ 0.00%
-+ 0.00%

Akari Therapeutics Announces Abstract Acceptance For Online Publication At American Society Of Clinical Oncology Annual Meeting 2026

Benzinga·04/21/2026 13:01:54
Listen to the news

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing modulating payloads, today announced that its abstract has been accepted for online publication at the American Society of Clinical Oncology (ASCO) Annual Meeting 2026